Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Low-Dose ATG Has the Same Risk of CMV Reactivation after Allogeneic PBSCT As Ptcy, but Letemovir Is Effective in Preventing CMV Reactivation

Takahide Ara, Yuta Hasegawa, Hiroyuki Ohigashi, Toshihiro Matsukawa, Souichi Shiratori, Atsushi Yasumoto, Hideki Goto, Masahiro Onozawa, Masao Nakagawa, Kaoru Kahata, Tomoyuki Endo, Daigo Hashimoto, Takanori Teshima

Blood (2023) 142 (Supplement 1): 3546.

https://doi.org/10.1182/blood-2023-191306

Published: 2023

Journal Articles

Letermovir Is Effective for Prevention of Cytomegalovirus Reactivation in HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide

Takahide Ara, Yuta Hasegawa, Hiroyuki Ohigashi, Souichi Shiratori, Atsushi Yasumoto, Hideki Goto, Junichi Sugita, Masahiro Onozawa, Masao Nakagawa, Kaoru Kahata, Daigo Hashimoto, Takanori Teshima

Blood (2021) 138 (Supplement 1): 2858.

https://doi.org/10.1182/blood-2021-152116

Published: 2021

Journal Articles

HLA-B Leader Dimorphism Impacts on Outcomes of HLA-Matched Related/Unrelated Transplantation: Analysis of the Japanese Society for Transplantation and Cellular Therapy

Minoru Kanaya, Yasuo Morishima, Nobuyoshi Arima, Masahiro Hirayama, Souichi Shiratori, Noriko Doki, Yukiyasu Ozawa, Takahiro Fukuda, Masatsugu Tanaka, Masashi Sawa, Satoru Takada, Shuichi Ota, Toshiro Kawakita, Junya Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Satoko Morishima

Blood (2021) 138 (Supplement 1): 2919.

https://doi.org/10.1182/blood-2021-144669

Published: 2021

Journal Articles

Impact of Different Doses of Fludarabine in Fludarabine-Based Conditioning Regimen for Unrelated Bone Marrow Transplantation

Kodai Kuriyama, MD PhD, Shigeo Fuji, MD PhD, Noriko Doki, MD PhD, Yuta Katayama, MD PhD, Souichi Shiratori, Yukiyasu Ozawa, MD PhD, Takashi Ashida, MD PhD, Junya Kanda, MD, Takahiro Fukuda, Yoshiko Atsuta, MD PhD, Masao Ogata, MD PhD

Blood (2019) 134 (Supplement_1): 3258.

https://doi.org/10.1182/blood-2019-123926

Published: 2019

Journal Articles

Classical Empiric Antifungal Therapy Vs. D-Index Guided Early Therapy Using Micafungin for Persistent Febrile Neutropenia (CEDMIC trial): A Randomized Controlled Trial from Japan FN Study Group

Shun-Ichi Kimura, MD PhD, Yoshinobu Kanda, MD PhD, Masaki Iino, MD PhD, Takahiro Fukuda, MD PhD, Emiko Sakaida, MD PhD, Tatsuo Oyake, Hiroki Yamaguchi, MD PhD, Shin-ichiro Fujiwara, MD PhD, Junji Suzumiya, MD PhD, Akinao Okamoto, MD PhD, Hiroyuki Fujita, MD PhD, Yasushi Takamatsu, MD PhD, Yoshio Saburi, MD PhD, Jun Yamanouchi, MD PhD, Itaru Matsumura, MD, Souichi Shiratori, Moritaka Gotoh, MD PhD, Shingen Nakamura, MD PhD, Kazuo Tamura, MD PhD

Blood (2018) 132 (Supplement 1): 816.

https://doi.org/10.1182/blood-2018-99-111154

Published: 2018

Journal Articles

Comparable Survival Outcomes of Haploidentical Stem Cell Transplantation and Unrelated Bone Marrow Transplantation

Junichi Sugita, Yoshiko Atsuta, MD PhD, Mio Kurata, Hirohisa Nakamae, Naoki Kurita, Ken Ishiyama, MD PhD, Souichi Shiratori, Takahiro Fukuda, Kazuteru Ohashi, MD PhD, Yukiyasu Ozawa, Junya Kanda, MD, Tatsuo Ichinohe, MD PhD, Takanori Teshima

Blood (2018) 132 (Supplement 1): 4644.

https://doi.org/10.1182/blood-2018-99-114770

Published: 2018

Journal Articles

Feasibility and Kinetics of CD34+ Hematopoietic Cells Mobilization By Low-Dose Pegfilgrastim in Lymphoma Patients

Hideki Goto, MDPhD, Daisuke Hidaka, MD, Satoshi Yamamoto, MD PhD, Koji Hayasaka, Rie Michimata, Ikuko Kagawa, Kana Sunagoya, Hiroaki Iijima, Eiko Hayase, MD, Souichi Shiratori, MD PhD, Kohei Okada, MD PhD, Junichi Sugita, MD PhD, Masahiro Onozawa, MD PhD, Daigo Hashimoto, MD PhD, Kaoru Kahata, MD PhD, Katsuya Fujimoto, MD PhD, Tomoyuki Endo, MD PhD, Chikara Shimizu, MD PhD, Takanori Teshima, MD PhD

Blood (2017) 130 (Supplement 1): 4478.

https://doi.org/10.1182/blood.V130.Suppl_1.4478.4478

Published: 2017

Journal Articles

Dasatinib enhances the expansion of CD56 + CD3 − NK cells from cord blood

Junji Tanaka, Junichi Sugita, Souichi Shiratori, Akio Shigematsu, Masahiro Imamura

Blood (2012) 119 (25): 6175–6176.

https://doi.org/10.1182/blood-2012-03-416800

Published: 2012

NARROW

Low-Dose ATG Has the Same Risk of CMV Reactivation after Allogeneic PBSCT As Ptcy, but Letemovir Is Effective in Preventing CMV Reactivation

Letermovir Is Effective for Prevention of Cytomegalovirus Reactivation in HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide

HLA-B Leader Dimorphism Impacts on Outcomes of HLA-Matched Related/Unrelated Transplantation: Analysis of the Japanese Society for Transplantation and Cellular Therapy

Impact of Different Doses of Fludarabine in Fludarabine-Based Conditioning Regimen for Unrelated Bone Marrow Transplantation

Classical Empiric Antifungal Therapy Vs. D-Index Guided Early Therapy Using Micafungin for Persistent Febrile Neutropenia (CEDMIC trial): A Randomized Controlled Trial from Japan FN Study Group

Comparable Survival Outcomes of Haploidentical Stem Cell Transplantation and Unrelated Bone Marrow Transplantation

Feasibility and Kinetics of CD34+ Hematopoietic Cells Mobilization By Low-Dose Pegfilgrastim in Lymphoma Patients

Dasatinib enhances the expansion of CD56 + CD3 − NK cells from cord blood

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only